Inactief instrument

Andere talen Advanced Medical Isotope Corp. Other OTC

Aandelen

US00765X1028

slotkoers Other OTC Andere beurzen
- ^USD	-

09/05	Vivos Inc. Rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
18/03	Vivos Inc. Rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation	20/12
Vivos Inc. Announces Radiogel(TM) Precision Radionuclide Therapy(TM) Receives FDA Breakthrough Device Designation	20/12
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
Vivos : Quarterly Progress Report - Form 8-K	11-10-23
Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics	07-08-23
Vivos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04-08-23
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	04-05-23
Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	04-05-23
VIVOS INC : Unregistered Sale of Equity Securities (form 8-K)	02-05-23
VIVOS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	01-03-23
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01-03-23
Vivos Inc. Auditor Raises 'Going Concern' Doubt	01-03-23
Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy	11-01-23
Vivos Inc Files A New Patent on Alternate Particles for Precision Radionuclide Therapy	11-01-23
Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment	03-01-23
Vivos Inc. Files New Patent on Precision Radionuclide Therapy Support System Equipment	03-01-23
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	19-10-22
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	19-10-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Advanced Medical Isotope Corp. Other OTC

Aandelen

US00765X1028

Andere talen

Filters